Drugs / aged garlic extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01168700 | Nov 2009 → Aug 2010 | metabolic syndrome X | Universidad de Santander | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01534910 Comparator | May 2012 → Dec 2014 | metabolic syndrome X | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aged garlic extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01534910 ↗ |
| Route | Oral | “Fifty-five patients with MetS (mean ± SD age: 58.7 ± 6.7 y; 71% men) were prospectively assigned to consume 2400 mg AGE/d (27 patients) or placebo (28 patients) orally.” PMID 26764322 ↗ Jan 2016 |